Trademark applications and grants for Olix Pharmaceuticals, Inc.. Olix Pharmaceuticals, Inc. has 1 trademark applications. The latest application filed is for "OLIX"
State Incorporated | KOREA, REPUBLIC OF |
Entity Type | CORPORATION |
Address | 1014, 17, Daehak 4-ro, Yeongtong-gu, Suwon-si Gyeonggi-do KOREA, REPUBLIC OF |
Patent Application | Date |
---|---|
LONG DOUBLE-STRANDED RNA FOR RNA INTERFERENCE 20210285001 - 16/484643 LEE; Dong Ki | 2021-09-16 |
RNA-INTERFERENCE-INDUCING NUCLEIC ACID MOLECULE ABLE TO PENETRATE INTO CELLS, AND USE THEREFOR 20210207137 - 17/110640 HONG; Sun Woo | 2021-07-08 |
TREATMENT OF ANGIOGENESIS-ASSOCIATED DISEASES USING RNA COMPLEXES THAT TARGET ANGPT2 AND PDGFB 20200123548 - 16/667398 LEE; Dong-Ki ;   et al. | 2020-04-23 |
TREATMENT OF ATOPIC DERMATITIS AND ASTHMA USING RNA COMPLEXES THAT TARGET IL4Ra, TRPA1, OR F2RL1 20200109405 - 16/514569 LEE; Dong-Ki ;   et al. | 2020-04-09 |
ASYMMETRIC siRNA FOR INHIBITING EXPRESSION OF MALE PATTERN HAIR LOSS TARGET GENE 20190382771 - 16/486833 HONG; Sun Woo ;   et al. | 2019-12-19 |
Mark Image Registration | Serial | Trademark Application Date |
---|---|
![]() "OLIX" 79334635 |
OLIX 2021-12-24 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.